1
|
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.
|
Lancet
|
2007
|
5.65
|
2
|
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
|
Clin Infect Dis
|
2014
|
1.58
|
3
|
Renal safety of tenofovir in HIV treatment-experienced patients.
|
AIDS
|
2004
|
1.50
|
4
|
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.
|
Nephrol Dial Transplant
|
2005
|
1.49
|
5
|
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
|
Hepatology
|
2008
|
1.47
|
6
|
Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.
|
J Exp Med
|
2005
|
1.43
|
7
|
Urolithiasis in HIV-positive patients treated with atazanavir.
|
Clin Infect Dis
|
2007
|
1.23
|
8
|
Coronary artery disease in HIV infected patients.
|
Intensive Care Med
|
2003
|
1.18
|
9
|
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.
|
J Acquir Immune Defic Syndr
|
2010
|
1.17
|
10
|
Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients.
|
J Acquir Immune Defic Syndr
|
2003
|
1.11
|
11
|
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
|
J Acquir Immune Defic Syndr
|
2012
|
1.01
|
12
|
Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone.
|
J Antimicrob Chemother
|
2010
|
1.00
|
13
|
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).
|
Vaccine
|
2005
|
0.99
|
14
|
Cytokines in HIV-associated cardiomyopathy.
|
Int J Cardiol
|
2007
|
0.99
|
15
|
Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome.
|
Antimicrob Agents Chemother
|
2004
|
0.95
|
16
|
HIV-associated vascular diseases: structural and functional changes, clinical implications.
|
Int J Cardiol
|
2009
|
0.94
|
17
|
Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study.
|
Clin Pharmacokinet
|
2007
|
0.92
|
18
|
Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
|
Antivir Ther
|
2012
|
0.89
|
19
|
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.
|
BMC Infect Dis
|
2010
|
0.89
|
20
|
Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
|
J Hepatol
|
2011
|
0.89
|
21
|
Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial.
|
J Acquir Immune Defic Syndr
|
2009
|
0.88
|
22
|
Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.
|
Curr HIV Res
|
2009
|
0.88
|
23
|
Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients.
|
Lab Invest
|
2004
|
0.88
|
24
|
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.
|
J Hepatol
|
2005
|
0.83
|
25
|
Eradication of an outbreak of vancomycin-resistant Enterococcus (VRE): the cost of a failure in the systematic screening.
|
Antimicrob Resist Infect Control
|
2013
|
0.82
|
26
|
Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
|
J Hepatol
|
2009
|
0.81
|
27
|
Non-O:1 and non-O:139 Vibrio cholerae septicemia and pyomyositis in an immunodeficient traveler returning from Tunisia.
|
Travel Med Infect Dis
|
2006
|
0.80
|
28
|
Cerebrovascular diseases in HIV-infected patients.
|
Curr HIV Res
|
2009
|
0.80
|
29
|
Efficacy of etravirine for treatment of acute HIV meningoencephalitis.
|
Clin Infect Dis
|
2009
|
0.79
|
30
|
The pavia consensus statement.
|
AIDS
|
2003
|
0.78
|
31
|
Liver transplantation in patients with HIV infection.
|
J Hepatol
|
2003
|
0.78
|
32
|
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
|
AIDS
|
2015
|
0.77
|
33
|
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
|
AIDS
|
2013
|
0.77
|
34
|
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
|
PLoS One
|
2013
|
0.77
|
35
|
[Liver transplantation for patients infected with both HIV and HCV or HIV and HBV].
|
Med Sci (Paris)
|
2007
|
0.76
|
36
|
Initial human herpesvirus-8 rash and multicentric Castleman disease.
|
Clin Infect Dis
|
2008
|
0.76
|
37
|
Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation.
|
Liver Transpl
|
2009
|
0.76
|
38
|
Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
|
Eur J Gastroenterol Hepatol
|
2017
|
0.75
|
39
|
[Anti-Jo1 antibodies syndrome in an HIV-infected patient].
|
Ann Med Interne (Paris)
|
2002
|
0.75
|
40
|
Photo quiz. Dyspnea and fever in an allogeneic stem cell recipient.
|
Clin Infect Dis
|
2015
|
0.75
|
41
|
[The HIV-infected traveler: infectious risks and prevention].
|
Presse Med
|
2007
|
0.75
|
42
|
[Therapeutic education of the patient infected with HIV].
|
Soins
|
2009
|
0.75
|
43
|
[Infections at risk for epidemic or biological threat. Importance of the initial management of suspect patients].
|
Presse Med
|
2011
|
0.75
|
44
|
Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010.
|
Liver Int
|
2014
|
0.75
|
45
|
[Liver transplantation in patients with HIV: indications, limits, perspectives].
|
Gastroenterol Clin Biol
|
2003
|
0.75
|